GENE ONLINE|News &
Opinion
Blog

Cancer
First Targeted Therapy for HER2-Low Breast Cancer Approved by FDA
2022-08-05
LOCOcyte – Avenge Bio’s Potential Treatment for Ovarian Cancer gets FDA Clearance
2022-08-03
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
AstraZeneca Calls Off Monalizumab Study With Innate After Phase 3 Disappoints
2022-08-02
Bristol Myers Squibb Provides an Update on Kidney Cancer Treatment
2022-08-01
Taiwan’s CancerFree Bio Showcases World’s First Commercialized Personalized Cancer Profile
2022-08-01
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
How Governments Around the World Should Respond to the Mounting Costs of Gene and Cell Therapy?
2022-07-08
Why CRY2 matters: Studying Control of Plants and Human Growth
2022-06-20
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
Antitumor Response of Left-handed Z-DNA Reinvigorates Immunotherapy’s Efficacy
2022-06-02
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Cowpea Mosaic Virus Sheds Light on Cancer Therapy
2022-05-11
FDA Plans to Prohibit Menthol Cigarettes and Flavored Cigars to Decrease Youth Smokers
2022-04-29
1 2 3 4 22
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scroll to Top